We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
A new report by The Institute of Cancer Research, London (ICR) has revealed an increase of nearly one year in delay between clinical trials, regulatory approvals and patient access to new cancer medications....